본문

  1. Home
5 Results:AA:MIC PP:ELSEVIER INC 0.124 sec.
RSS 
다국어입력
 상세검색
 신착검색
선택출력 선택엑셀내보내기
1
Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis.
Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis.
Pierre D Delmas,, | Elsevier Inc | 2008 ,
2
Severe vitamin D deficiency in Swiss hip fracture patients
Severe vitamin D deficiency in Swiss hip fracture patients
Bischoff-Ferrari, H. A., | Elsevier Inc | 2008 ,
3
Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients:Proposal of diagnostic criteria using FGF23 measurement
Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients:Proposal of diagnostic criteria using FGF23 measurement
Endo, I., | Elsevier Inc | 2008 ,
4
Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa
Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa
Utz Andrea L,, | Elsevier Inc | 2008 ,
5
Oxygen tension regulates preosteocyte maturation and mineralization
Oxygen tension regulates preosteocyte maturation and mineralization
Zahm Adam M,, | Elsevier Inc | 2008 ,
처음1마지막